SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-23-000192
Filing Date
2023-12-11
Accepted
2023-12-11 07:05:52
Documents
18
Period of Report
2023-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20231210.htm   iXBRL 8-K 32589
2 EX-99.1 a2619serpinpcbaglin1.htm EX-99.1 7097
3 EX-99.2 centessaannouncespresentat.htm EX-99.2 21967
8 GRAPHIC a2619serpinpcbaglin1001.jpg GRAPHIC 249328
9 GRAPHIC image_0.jpg GRAPHIC 65390
10 GRAPHIC part5serpindata.jpg GRAPHIC 30518
  Complete submission text file 0001847903-23-000192.txt   730981

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20231210.xsd EX-101.SCH 2737
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20231210_def.xml EX-101.DEF 16868
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20231210_lab.xml EX-101.LAB 34074
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20231210_pre.xml EX-101.PRE 18275
12 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20231210_htm.xml XML 4495
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 231476900
SIC: 2834 Pharmaceutical Preparations